6
SPONSORED BY: 20+ PRESENTATIONS 5+ HOURS OF NETWORKING 100+ PROFESSIONALS Uniting Team Expertise and Performance, Maximizing Quality Oversight During Review, and Maintaining Regulatory Compliance in All Multimedia Promotional Materials PROMOTIONAL REVIEW COMMITTEE COMPLIANCE & BEST PRACTICES ALL-NEW SESSIONS ON: Empowering Coordinators to Streamline PRC Operations Upgrading Submission Techniques for Adaptive Promotional Websites Confronting Compliance Challenges from Retail Pharmacy Promotions Managing a Multi-Company Review of Co-Promoted Drugs October 17-18, 2016 // The Madison Hotel // Morristown, NJ A SPECIAL FOCUS ON PRC CHALLENGES FOR: Orphan Drugs Generic Drugs Biosimilars Medical Devices 4TH “Presentations were entertaining, relevant, on-point and useful. I was very impressed with the knowledge and best practices available.” —Senior Regulatory Affairs Specialist, Ad/Promo, ABBOTT VASCULAR CELGENE Analyzes Compliance Needs for Promotional Apps Lisa Drucker Senior Director, Regulatory Affairs SUNOVION Plans Long-Term Budgeting for PRC Activities Elizabeth Theophile Director, Promotional Materials Compliance Management PERNIX Safeguards PRC Talent After Corporate Mergers and Acquisitions Elke Carter Director, Regulatory Affairs ASTRAZENECA Updates PRC Techniques for Search Engine Optimization Yemisi Oluwatosin Director, Promotional Regulatory Affairs INTERACTIVE WORKSHOP: DEVELOP AND MAINTAIN A PROMOTIONAL CLAIMS COMPENDIUM FOR EACH PRODUCT YOUR CO-CHAIRS: John Marcus Associate Director, Regulatory Affairs ABBVIE Rebecca Rebmann Senior Promotional Review Associate UNITED THERAPEUTICS For More Information Call 866–207–6528 or Visit www.exlevents.com/reviewboards

4TH PROMOTIONAL REVIEW COMMITTEE …info.exlevents.com/rs/195-NER-971/images/C802_Web.pdfact on expert comments for your entire drug and device portfolio. This year, our all-new speaking

Embed Size (px)

Citation preview

Page 1: 4TH PROMOTIONAL REVIEW COMMITTEE …info.exlevents.com/rs/195-NER-971/images/C802_Web.pdfact on expert comments for your entire drug and device portfolio. This year, our all-new speaking

SPONSORED BY:

20+ PRESENTATIONS

5+HOURS OF NETWORKING

100+ PROFESSIONALS

Uniting Team Expertise and Performance, Maximizing Quality Oversight During Review, and Maintaining Regulatory Compliance in All Multimedia Promotional Materials

PROMOTIONAL REVIEW COMMITTEE COMPLIANCE

& BEST PRACTICES

ALL-NEW SESSIONS ON: ➜ Empowering Coordinators to Streamline PRC

Operations

➜ Upgrading Submission Techniques for Adaptive Promotional Websites

➜ Confronting Compliance Challenges from Retail Pharmacy Promotions

➜ Managing a Multi-Company Review of Co-Promoted Drugs

October 17-18, 2016 // The Madison Hotel // Morristown, NJ

A SPECIAL FOCUS ON PRC CHALLENGES FOR: ➜ Orphan Drugs

➜ Generic Drugs

➜ Biosimilars

➜ Medical Devices

4TH

“Presentations were entertaining, relevant, on-point and useful. I was very impressed with the knowledge and best practices available.”

—Senior Regulatory Affairs Specialist, Ad/Promo, ABBOTT VASCULAR

CELGENE Analyzes Compliance Needs for Promotional Apps Lisa Drucker Senior Director, Regulatory Affairs

SUNOVION Plans Long-Term Budgeting for PRC ActivitiesElizabeth Theophile Director, Promotional Materials Compliance Management

PERNIX Safeguards PRC Talent After Corporate Mergers and AcquisitionsElke Carter Director, Regulatory Affairs

ASTRAZENECA Updates PRC Techniques for Search Engine OptimizationYemisi OluwatosinDirector, Promotional Regulatory Affairs

INTERACTIVE WORKSHOP: DEVELOP AND MAINTAIN A PROMOTIONAL CLAIMS COMPENDIUM FOR EACH PRODUCT

YOUR CO-CHAIRS:

John Marcus Associate Director, Regulatory AffairsABBVIE

Rebecca Rebmann Senior Promotional Review AssociateUNITED THERAPEUTICS

For More Information Call 866–207–6528 or Visit www.exlevents.com/reviewboards

Page 2: 4TH PROMOTIONAL REVIEW COMMITTEE …info.exlevents.com/rs/195-NER-971/images/C802_Web.pdfact on expert comments for your entire drug and device portfolio. This year, our all-new speaking

DEAR COLLEAGUE,Even the best knowledge of OPDP expectations for promotional materials will do you no good, unless you can construct and manage a promotional review committee that functions as a true team, meeting all its deadlines and adapting to the unique compliance challenges that come with specialized therapeutics and disease indications.

The 4th PRC Compliance & Best Practices conference is the only summit that focuses specifically on building and benchmarking the teamwork of your review committee. Join us in Morristown, New Jersey to ensure your PRC is prepared to generate, collect and constructively act on expert comments for your entire drug and device portfolio.

This year, our all-new speaking faculty tackles the most pressing promotional compliance topics — as chosen by YOU, our audience! These never-before-heard discussions will empower you to:

• Select and train the ideal coordinator to drive your PRC process

• Design compliant promotional messaging on apps and social networks

• Go beyond the letter of the law to protect your company’s reputation among patients for depicting their needs seriously and respectfully

• Diversify your PRC’s skill sets to meet the unique approval challenges of generic drugs, biosimilars, orphan drugs, medical devices and much more

• Maintain PRC talent and cohesion after corporate mergers and acquisitions

Plus: Return to work armed with even more information by attending our in-depth interactive workshop devoted to best practices for assembling and using a claims compendium for each product under review!

I look forward to welcoming you to the premier platform for discussing and learning about

promotional review strategies this fall!

Matt GreenbaumMatt Greenbaum

Production Team Leader, ExL Events

[email protected]

• Promotion Review/PRC/MPRC/PMRC

• Material Review

• Regulatory Promotion and Advertising/PromoAd/AdProm/AdPromo/Copy Editing

• Regulatory Affairs/Processes

• Compliance/Promotional Compliance

• Labeling

• Medical Affairs/Review

• Medical Information

• Communications

• Medical Communications/Information

• Medical Science Liaisons

• Marketing/Marketing Operations/Communications/Services

• Commercial Operations

• Brand Management/Product Management/Brand Marketing

• Legal Affairs/Counsel/Regulatory Counsel

WHO SHOULD ATTEND This conference is specifically designed for pharma, biotech and med device professionals responsible for:

This event is also of interest to:

• CRM/Data Management Software Suppliers

• MLR Process Vendors and Facilitators

• Advertising/Marketing Agencies

• Regulatory Consultants

• Medical Writing Firms

• Law Firms

SPONSORSHIP AND EXHIBITION OPPORTUNITIESDo you want to spread the word about your organization’s solutions and services to potential clients who will be attending this event? Take advantage of the opportunity to exhibit, underwrite an educational session, host a networking event or distribute promotional items to attendees. ExL Events will work closely with you to customize a package that will suit all of your needs. To learn more about these opportunities, please contact Eric Morrin, Senior Business Development Manager, at [email protected] or 212-400-6228.

“Great content. Very thorough explanation of committee roles and importance.”

—Contracts Manager, SPECTRUM PHARMA

VENUETHE MADISON HOTELOne Convent RoadMorristown, NJ 07960

To make reservations, please call 973-285-1800 or 1-800-526-0729 and request the negotiated rate for ExL’s October Meeting. The group rate is available until September 26. Please book your room early, as rooms available at this rate are limited.

*ExL Events, Inc. is not affiliated with Exhibition Housing Management (EHM)/Exhibitors Housing Services (EHS) or any third-party booking agencies, housing bureaus or travel and events companies. In the event that an outside party contacts you for any type of hotel or travel arrangements, please disregard these solicitations and kindly email us at [email protected]. ExL has not authorized these companies to contact you and we do not verify the legitimacy of the services or rates offered. Please book your guest rooms through ExL’s reserved guest room block using the details provided.

For More Information Call 866–207–6528 or Visit www.exlevents.com/reviewboards

Page 3: 4TH PROMOTIONAL REVIEW COMMITTEE …info.exlevents.com/rs/195-NER-971/images/C802_Web.pdfact on expert comments for your entire drug and device portfolio. This year, our all-new speaking

MONDAY, OCTOBER 17, 2016 // WORKSHOP DAY

12:00 REGISTRATION

1:00 CO-CHAIRS’ OPENING REMARKS John Marcus, Associate Director, Regulatory Affairs, ABBVIE Rebecca Rebmann, Senior Promotional Review Associate,

UNITED THERAPEUTICS

PROMOTIONAL REVIEW BREAKTHROUGHS FOR NEW MEDIA

1:15 CALCULATE NEW STRATEGIES FOR THE REVIEW AND SUBMISSION OF ADAPTIVE PROMOTIONAL WEBSITES

Regulatory expectations for adaptive websites remain ambiguous. There is no strictly defined preferred method for submitting the appearance of an adaptive website, and some of the potential methods are far more time- and labor-intensive than others.

[ Build on previous successes in website promotional review [ Target the best methods for presenting and submitting multiple layouts of

adaptive websites to OPDP [ Confront the likelihood of website reviews that last months, possibly with

subsequent rounds canceling out earlier ones

John Marcus, Associate Director, Regulatory Affairs, ABBVIE

1:45 OVERCOME THE HURDLES OF REVIEWING SEARCH ENGINE MARKETING TECHNIQUES

PRCs oversee search engine optimization and keyword marketing, a new field that leaves many reviewers struggling. Your organization needs to firmly establish and categorize which search engine uses it sees as promotional, and then build a mechanism for reviewing these.

[ Differentiate between organic and paid searches [ Finalize the methods for reviewing and submitting results to OPDP [ Bring in digital experts to educate reviewers on the specific promotional

aspects of SEOs

Yemisi Oluwatosin, Director, Promotional Regulatory Affairs, ASTRAZENECA

2:15 BUILD CONFIDENCE IN THE COMPLIANT DESIGN OF PROMOTIONAL APPS

App designers may be both very sophisticated at designing multi-staged product for your review while simultaneously using more rudimentary techniques when presenting the same apps to FDA. Understanding the best way to track user feedback while streamlining the regulatory submission process is critical to gaining market presence for your promotional apps.

[ Move on from primitive methods that required hundreds of screenshots [ Harmonize an internal dynamic review system with your FDA submission

methods [ Target the best methods for capturing user comments and submitting them to

the FDA as needed Lisa Drucker, Senior Director, Regulatory Affairs, CELGENE

Ilyssa Levins, President, CENTER FOR COMMUNICATION COMPLIANCE

IMPROVE TRAINING AND STRUCTURAL SKILLS FOR PRC MEMBERS

2:45 ONBOARD NEW TALENT AND LEVERAGE YOUR PRC PROCESS TO INCREASE QUALITY OF MATERIALS AND APPROVAL TIMES

An ideal PRC would spend less time editorializing and more time approving material assets, but a high level of turnover — particularly in marketing departments — can be an obstacle. New prioritization and management techniques can help make sure you always have materials ready for review and publication, and that your talent is producing review-ready content.

[ De-prioritize other reviewer activities to add extra time to the docket [ Employ new resource modeling projects [ Avoid contract resources that don’t deliver sufficient project-based

orientation or effectively manage contract resources

Ariail Roberts, Senior Manager, Review Services, UCB PHARMA

3:15 CASE STUDY: IMPROVE THE EFFECTIVENESS AND EFFICIENCY OF PRCS

Anand Kiran, Executive Vice President, Global Operations, Medical Solutions, INDEGENE

Lu Ann Binda, North America Lead, Promotional Operations, PFIZER

3:45 NETWORKING BREAK

4:15 IMPROVE PRC PERFORMANCE THROUGH ONLINE REVIEW MEETINGS

If your entire PRC process is held “live,” it tends to be a bigger drain on time and resources. By prioritizing an e-review system, you can give your team more flexibility, avoid inefficiencies and better meet your shared performance goals.

[ Position online review as your default method unless coordinators find some reviewer comments problematic

[ Quantify the differences in number and speed of PRC meetings [ Keep lines open between the coordinator and PRC members

Rebecca Burnett, Senior Director, Marketing Services, MYLAN

4:45 CLARIFY EDUCATIONAL CONTENT AND CONTEXT AMONG MSLs

PRC individuals may also oversee review for items used by MSLs, yet each must remember that this is a separate review process with its own guidelines and goals. Guaranteeing that your MSL understands the differences between messages provided in each venue can help you avoid redundant messaging and regulatory risk.

[ Clamp down on the reuse of internally reviewed material at external venues [ Create universal education guidelines and training for new MSL staff [ Expand training to accommodate new team members brought on for

product launches

Deirdre Smith, Medical Information Lead, CSL BEHRING

8:00 REGISTRATION AND CONTINENTAL BREAKFAST

9:00 DEVELOP AND MAINTAIN A PROMOTIONAL CLAIMS COMPENDIUM FOR EACH PRODUCT

It is the brand team’s responsibility to develop a core claims compendium, with input from the PRC. Challenges arise when you encounter rapid industry changes and the spread to new media formats. If a new claim does not exist in your core claims guide, what is the process under which you could use it? Additionally, the construction and word choice in a new claim can significantly impact your review process. Does abbreviating a phrase or omitting a bullet point to save space change the meaning of what is presented? If so, how should you proceed? This workshop will address how to:

[ Distinguish between the perceived definitions of claims among both marketing and reviewers [ Prepare to consider even nonverbal background material as being a claim or claim-related [ Specify whether new visual aids or website elements need separate concept preapproval processes [ Conceptualize the impact of wording changes as perceived by regulatory reviewers [ Firmly instill knowledge of which terms can be modified and abbreviated and which cannot [ Overcome the challenges of modifying DTC and healthcare provider material

Rebecca Rebmann, Senior Promotional Review Associate, UNITED THERAPEUTICS Denise Sanchez, Director, Commercial Regulatory Affairs, IRONWOOD PHARMACEUTICALS Yemisi Oluwatosin, Director, Promotional Regulatory Affairs, ASTRAZENECA

There will be a 30-minute networking break as part of the workshop.

12:00 LUNCHEON FOR WORKSHOP PARTICIPANTS

MONDAY, OCTOBER 17, 2016 // MAIN CONFERENCE, DAY ONE

For More Information Call 866–207–6528 or Visit www.exlevents.com/reviewboards

Page 4: 4TH PROMOTIONAL REVIEW COMMITTEE …info.exlevents.com/rs/195-NER-971/images/C802_Web.pdfact on expert comments for your entire drug and device portfolio. This year, our all-new speaking

TUESDAY, OCTOBER 18, 2016 // MAIN CONFERENCE, DAY TWO

8:00 CONTINENTAL BREAKFAST

8:45 CO-CHAIRS’ RECAP OF DAY ONE John Marcus, Associate Director, Regulatory Affairs, ABBVIE Rebecca Rebmann, Senior Promotional Review Associate, UNITED

THERAPEUTICS

9:00 ASSEMBLE THE TRAINING MANUALS THAT CAN BOOST THE EXPERTISE OF YOUR PRC

You can significantly revamp your promotional review techniques by focusing on the factors that cause reviewers to miss deadlines. If PRC member training is inconsistent, you can address this by designing detailed training manuals and e-learning modules that have a real chance of changing participant behavior.

[ Properly disseminate spot-check documents [ Prevent mixed messages from multiple teams that would confuse ad

agencies [ Standardize PRC processes across drugs and indications

Iris Gibbs, Associate Director, Regulatory Affairs, Advertising and Promotions, REGENERON

9:30 SIMPLIFY MULTI-COMPANY PROMOTIONAL REVIEW FOR CO-PROMOTED DRUGS When multiple drug companies co-develop and co-market a drug, it magnifies the logistical and time-management challenges PRCs face. There are several different ways to guide a joint effort, and you must bear in mind that both companies are being judged by each others’ efforts.

[ Weigh the advantages of parallel versus merged review committees [ Avoid redundant work and delays in co-promotions [ Rely on a combined team’s strengths when submitting materials for review

John Marcus, Associate Director, Regulatory Affairs, ABBVIE

10:00 CASE STUDY

Presented by VODORI

10:30 Networking Break

ADVANCED PRC APPLICATIONS FOR SPECIFIC PRODUCTS

11:00 CULTIVATE PRC SKILLS FOR BIOSIMILARS The first wave of FDA-approved biosimilars have hit the U.S. market, and with them come many new challenges and opportunities from a commercialization standpoint.

[ Share the latest best practice for winning physician and patient uptake for this new product class

[ Adapt the most useful lessons from biologics and generic drugs [ Case studies of early successes

Denise Sanchez, Director, Commercial Regulatory Affairs, IRONWOOD PHARMACEUTICALS

11:30 PREPARE FOR THE PROMOTIONAL REVIEW CHALLENGES RELEVANT TO ORPHAN DRUGS

Promotions for orphan drugs need to be very specifically targeted, with a small number of patients, healthcare providers and relevant media. Working with patient advocacy groups can be more effective than the routes traditionally favored by pharma companies.

[ Identify the journals and patient organizations that best fit your messaging [ Track and benefit from patient-to-patient recommendations and word of

mouth [ Build a dedicated social media promotional review strategy for orphan drugs

Deirdre Smith, Medical Information Lead, CSL BEHRING

12:00 SPOTLIGHT ON NEW SOCIAL MEDIA AND REGULATORY OPPORTUNITIES FOR MEDICAL DEVICES Advertising for medical devices is distinct from pharma, with less stringent regulations frequently overseen by the FTC instead of the FDA. This can yield greater flexibility when promoting medical devices on social media, as well as developing promotional apps for new devices.

[ Benefit from the new world of apps available for medical devices [ Differentiate between general and specific clearance [ Take advantage of less strict AdvaMed Codes

Bill Waller, Senior Corporate Counsel, VARIAN MEDICAL SYSTEMS

5:15 SHIFT THE ESTABLISHED CONTENT MANAGEMENT PARADIGM TOWARD A HOLISTIC AND MULTICHANNEL APPROACH

In order to accommodate and better manage costs and resources across all types of marketing materials, including the increasing use of digital materials, life sciences manufacturers have to utilize enhanced and streamlined approaches in the management and review of promotional materials. Based on research and experience in helping clients enhance the timeliness and impact of these activities, this session explores three areas that can shift promotional content management to a holistic and multichannel approachs.

[ Reuse content to increase efficiencies and reduce redundancies in global and regional markets

[ Leverage new technology, tools, and tactics to better manage cost and resources

[ Accommodate multiple communication channels and keeping their use compliant

Aditi Taylor, Principal, DELOITTE & TOUCHE LLP

Jyothi Fernandes, Senior Manager, DELOITTE & TOUCHE LLP

Bill Carter, Manager, DELOITTE & TOUCHE LLP

5:45 IMPROVE YOUR ADVANCED PLANNING AND BUDGETING FOR PRC ACTIVITIES

It is difficult for PRCs to handle high volumes of review material, you can get a better idea of just what the volume will be by working cross-functionally with regulatory, medical, legal and marketing colleagues. . By planning for fiscal quarters or even years into the future, you can better integrate it with the budgeting capacity of your marketing team and assure you have the resources available to support the projected volume.

[ Identify deliverables and tactics far in advance [ Work with planning experts from each participating specialty area [ Learn from other organizations that manage higher volumes

Elizabeth Theophile, Director, Promotional Materials Compliance

Management, SUNOVION

6:15 COCKTAIL NETWORKING RECEPTION sponsored by

7:15 Day One Concludes

“This is the only conference related to management of the PRC process. Content was relevant and engaging - really drove discussions.” —Marketing Services Project Coordinator, UCB PHARMA

For More Information Call 866–207–6528 or Visit www.exlevents.com/reviewboards

Page 5: 4TH PROMOTIONAL REVIEW COMMITTEE …info.exlevents.com/rs/195-NER-971/images/C802_Web.pdfact on expert comments for your entire drug and device portfolio. This year, our all-new speaking

12:30 LUNCHEON

1:30 OPTIMIZE THE ROLE OF LEGAL IN YOUR PRC Strong regulatory and medical reviewers are of the highest importance in promotional review; this allows legal to focus on overall initiatives from the FDA as well as any potential fraud and abuse concerns, rather than only considering one specific piece.

[ Emphasize the importance of concept meetings from a legal perspective [ Focus on issues that regulatory/medical reviewers do not or cannot, i.e., IP

issues, the Lanham Act, etc. [ Protect the reputation of your product and company

Marianne Slivkova, Director, Commercial Legal, ACORDA THERAPEUTICS

2:00 MAINTAIN PRC TALENT AND FLEXIBILITY AFTER CORPORATE MERGERS AND ACQUISITIONS After an M&A of a company with its own PRC structure, you need to carefully weigh whether to incorporate or dissolve this new committee. Otherwise, materials may slip through cracks and end up in the field without proper review.

[ Update risk tolerance based on the cultures of the merged companies [ Evaluate the methods and pros and cons of uniting PRCs [ Understand how improperly managed mergers can lead to OPDP letters

Elke Carter, Director, Regulatory Affairs, PERNIX THERAPEUTICS

2:30 Conference Concludes

Group Discount ProgramsOffers cannot be combined. Early Bird rates do not apply. To find out more on how you can take advantage of these group discounts, call 866–207–6528.

Save 25% per person when registering four For every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the program (must register four at one time).

Save 15% per person when registering three Can only send three? You can still save 15% off of each registration.

Registration FeesEARLY BIRD PRICING

Register by Friday, September 9, 2016

Conference and Workshop: $2,195

Conference Only: $1,895

STANDARD PRICING

Register After Friday, September 9, 2016

Conference and Workshop: $2,395

Conference Only: $2,095

ONSITE PRICING

Conference and Workshop: $2,495

Conference Only: $2,195

QUESTIONS? COMMENTS?Do you have any questions, comments on the program or specific topics you would like addressed? Would you like to get involved as a speaker, moderator or discussion leader? Please email Production Team Leader Matt Greenbaum at [email protected].

MEDIA PARTNERS

SPONSORED BY:

TERMS AND CONDITIONS: By registering for an ExL Events, Inc. (“ExL”) event, you agree to the following set of terms and conditions listed below:

REGISTRATION FEE: The fee includes the conference‚ all program materials‚ and designated continental breakfasts‚ lunches and refreshments.

PAYMENT: Make checks payable to ExL Events, Inc. and write C802 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full by the conference date. Any discount applied cannot be combined with any other offer and must be paid in full at the time of order. Parties must be employed by the same organization and register simultaneously to realize group discount pricing options.

**Please Note: There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague within five business days of any ExL conference.**

CANCELLATION AND REFUND POLICY: If you cancel your registration for an upcoming ExL event, the following policies apply, derived from the Start Date of the event:• Four weeks or more: A full refund (minus a $295 processing fee) or a voucher to another

ExL event valid for 12 months from the voucher issue date.• Less than four weeks: A voucher to another ExL event valid for 12 months from the

voucher issue date.• Five days or less: A voucher (minus a $395 processing and documentation fee) to another

ExL event valid for 12 months from the voucher issue date.To receive a refund or voucher, please email [email protected] or fax your request to 888-221-6750.

CREDIT VOUCHERS: Credit vouchers are valid for 12 months from date of issue. Credit vouchers are valid toward one (1) ExL event of equal or lesser value. If the full amount of said voucher is not used at time of registration, any remaining balance is not applicable now or in the future. Once a credit voucher has been applied toward a future event, changes cannot be made. In the event of cancellation on the attendees’ behalf, the credit voucher will no longer be valid.

ExL Events, Inc. does not and is not obligated to provide a credit voucher to registered attendee(s) who do not attend the event they registered for unless written notice of intent to cancel is received and confirmed prior to the commencement of the event.

SUBSTITUTION CHARGES: There will be an administrative charge of $300 to substitute, exchange and/or replace attendee badges with a colleague occurring within five business days of the conference.

ExL Events reserves the right to cancel any conference it deems necessary and will not be responsible for airfare‚ hotel or any other expenses incurred by registrants.

ExL Events’ liability is limited to the conference registration fee in the event of a cancellation and does not include changes in program date‚ content‚ speakers and/or venue.

*The opinions of ExL’s conference speakers do not necessarily reflect those of the companies they represent, nor ExL Events, Inc.

Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, significant effort to find a suitable replacement will be made. The content in ExL slide presentations, including news, data, advertisements and other information, is provided by ExL’s designated speakers and is designed for informational purposes for its attendees. It is NOT INTENDED for purposes of copywriting or redistribution to other outlets without the express written permission of ExL’s designated speaking parties. Neither ExL nor its content providers and/or speakers and attendees shall be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. EXL EVENTS, INC. EXPRESSLY DISCLAIMS ALL WARRANTIES, EXPRESSED OR IMPLIED, AS TO THE ACCURACY OF ANY CONTENT PROVIDED, OR AS TO THE FITNESS OF THE INFORMATION FOR ANY PURPOSE. Although ExL makes reasonable efforts to obtain reliable content from third parties, ExL does not guarantee the accuracy of, or endorse the views or opinions given by any third-party content provider. ExL presentations may point to other websites that may be of interest to you, however ExL does not endorse or take responsibility for the content on such other sites.

www.exlevents.com/reviewboards

[email protected]

866-207-6528

888-221-6750

ExL Events, Inc.494 8th Avenue, Fourth FloorNew York, NY 10001

Way

s to

Regi

ster

5

Page 6: 4TH PROMOTIONAL REVIEW COMMITTEE …info.exlevents.com/rs/195-NER-971/images/C802_Web.pdfact on expert comments for your entire drug and device portfolio. This year, our all-new speaking

□ Yes! Register me for the conference only!

Name: Title:

Company:

Dept.:

Address:

City: State: Zip:

Email:

Phone: Fax:

□ Yes! Register me for the conference + workshop!

Conference Code: C802

Please contact me:

I'm interested in marketing opportunities at this event.

I wish to receive email updates on ExL Pharma's upcoming events.

Method of Payment: Check Credit Card

Make checks payable to ExL Events, Inc.

Card Type: MasterCard Visa Discover AMEX

Card Number: Exp. Date:

Name on Card: CVV:

Signature:

Uniting Team Expertise and Performance, Maximizing Quality Oversight During Review, and Maintaining Regulatory Compliance in All Multimedia Promotional Materials

4TH

PROMOTIONAL REVIEW COMMITTEE COMPLIANCE

& BEST PRACTICES

Lisa Drucker Senior Director, Regulatory Affairs

CELGENE

Elizabeth Theophile Director, Promotional Materials Compliance Management

SUNOVION

Elke Carter Director, Regulatory Affairs PERNIX

John Marcus Associate Director, Regulatory Affairs

ABBVIE

Yemisi Oluwatosin Director, Promotional Regulatory Affairs ASTRAZENECA

October 17-18, 2016 // The Madison Hotel // Morristown, NJ

www.exlevents.com/reviewboards

[email protected]

866-207-6528

888-221-6750

ExL Events, Inc.494 8th Avenue, Fourth FloorNew York, NY 10001

5 Ways to Register

For More Information Call 866–207–6528 or Visit www.exlevents.com/reviewboards